$IMMX B of A Securities Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $27
B of A Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a Buy rating and announces Price Target of $27.
Jay Tissera
Posts (2)
IMMX B of A Securities Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $27
B of A Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a Buy rating and announces Price Target of $27.